We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+6.47%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$67.8B
AUM Growth
+$4.58B
Cap. Flow
+$1.48B
Cap. Flow %
2.18%
Top 10 Hldgs %
13.11%
Holding
4,400
New
669
Increased
1,360
Reduced
1,072
Closed
1,112

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$813M
2
BAC icon
Bank of America
BAC
+$503M
3
MSFT icon
Microsoft
MSFT
+$312M
4
INTU icon
Intuit
INTU
+$251M
5
MU icon
Micron Technology
MU
+$240M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$817M
2
AVGO icon
Broadcom
AVGO
+$687M
3
AMZN icon
Amazon
AMZN
+$633M
4
ACN icon
Accenture
ACN
+$448M
5
V icon
Visa
V
+$399M

Sector Composition

Rank Sector Weight
1 Technology 15.84%
2 Industrials 10.6%
3 Healthcare 9.97%
4 Financials 9.88%
5 Consumer Discretionary 8.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAPR icon
3376
Capricor Therapeutics
CAPR
$223M
-14,433
Closed -$68.8K
CARE icon
3377
Carter Bankshares
CARE
$766M
-1,132
Closed -$17.1K
CARR icon
3378
Carrier Global
CARR
$51B
-1,644,281
Closed -$104M
CASI
3379
DELISTED
CASI Pharmaceuticals
CASI
-100
Closed -$550
CATX icon
3380
Perspective Therapeutics
CATX
$332M
-83,346
Closed -$831K
CBAN icon
3381
Colony Bankcorp
CBAN
$465M
-5
Closed -$61
CBAT icon
3382
CBAK Energy Technology Ltd
CBAT
$44.3M
-178
Closed -$244
CBFV icon
3383
CB Financial Services
CBFV
$186M
-1
Closed -$23
CCCC icon
3384
C4 Therapeutics
CCCC
$385M
-258,426
Closed -$1.19M
CCGWW
3385
Cheche Group Inc Warrant
CCGWW
-2,400
Closed -$84
CCI icon
3386
Crown Castle
CCI
$33.3B
-139,127
Closed -$15.3M
CCJ icon
3387
Cameco
CCJ
$37.6B
-2,096
Closed -$91.4K
CCK icon
3388
Crown Holdings
CCK
$12.8B
-14,837
Closed -$1.1M
CCOI icon
3389
Cogent Communications
CCOI
$676M
-105,163
Closed -$5.94M
CCRD
3390
DELISTED
CoreCard
CCRD
-8,318
Closed -$121K
CCRN
3391
DELISTED
Cross Country Healthcare
CCRN
-19,478
Closed -$270K
CDTX
3392
DELISTED
Cidara Therapeutics
CDTX
-2
Closed -$24
CEPU
3393
Central Puerto
CEPU
$2.29B
-7,046
Closed -$63.9K
CFFN icon
3394
Capitol Federal Financial
CFFN
$1.09B
-10,925
Closed -$60K
CFO icon
3395
VictoryShares US 500 Enhanced Volatility Wtd ETF
CFO
$417M
-50
Closed -$3.21K
CG icon
3396
Carlyle Group
CG
$16.6B
-70,307
Closed -$2.82M
CGEM icon
3397
Cullinan Oncology
CGEM
$1.01B
-190,520
Closed -$3.32M
CGEN icon
3398
Compugen
CGEN
$222M
-29,516
Closed -$49.6K
CGUS icon
3399
Capital Group Core Equity ETF
CGUS
$11.4B
-135
Closed -$4.35K
CHMG icon
3400
Chemung Financial Corp
CHMG
$393M
-74
Closed -$3.55K

Similar funds

Qube Research & Technologies (QRT)'s Q3 2024 Portfolio in Review

As of Q3 2024, Qube Research & Technologies (QRT) held 4,400 positions worth $67.8B, up 7.2% from $63.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Qube Research & Technologies (QRT)'s Q3 2024 filing shows 669 new, 1,360 increased, 1,072 reduced and 1,112 closed positions. Its largest new stake was Ferguson: 1,075,627 shares worth $214M. The largest sale was Apple, an estimated $817M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Industrials and Healthcare.

  • Qube Research & Technologies (QRT)'s largest Q3 2024 buy was Ferguson: 1,075,627 shares worth $214M.
  • Qube Research & Technologies (QRT) added most to NVIDIA in Q3 2024, an estimated $813M increase.
  • Qube Research & Technologies (QRT)'s biggest Q3 2024 reduction was Apple, cutting an estimated $817M.
  • Qube Research & Technologies (QRT) fully exited Broadcom in Q3 2024, selling an estimated $687M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 13% of its $67.8B portfolio in Q3 2024.
  • Qube Research & Technologies (QRT) opened 669 new positions and closed 1,112 in Q3 2024.
  • Qube Research & Technologies (QRT)'s portfolio value rose 7.2% quarter-over-quarter to $67.8B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.